Atalanta Sosnoff Capital’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Atalanta Sosnoff Capital’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-75,000	Closed	-$925K	–	107
2020 Q2	$925K	Buy	+75,000	New	+$848K	0.03%	77
2015 Q4	–	Sell	-793,515	Closed	-$44.8M	–	102
2015 Q3	$44.8M	Buy	793,515 +252,733	+47%	+$16.4M	1.43%	33
2015 Q2	$32M	Sell	540,782 -68,721	-11%	-$4.24M	0.88%	48
2015 Q1	$38M	Sell	609,503 -43,423	-7%	-$2.52M	1.01%	48
2014 Q4	$37.5M	Buy	+652,926	New	+$36.4M	0.93%	51

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

Atalanta Sosnoff Capital's TEVA Position: Q3 2020 in Review

Atalanta Sosnoff Capital sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q3 2020, closing a stake of 75,000 shares — an estimated $925K sold.

Atalanta Sosnoff Capital first reported a position in TEVA in Q4 2014 and held it in 5 quarters. The position peaked at $44.8M in Q3 2015. 444 funds tracked by Wall St. Rank hold TEVA as of Q3 2020.

Atalanta Sosnoff Capital reported no remaining Teva Pharmaceutical Industries Limited position as of Q3 2020 after selling out during the quarter.
Atalanta Sosnoff Capital sold 75,000 Teva Pharmaceutical Industries Limited shares in Q3 2020, an estimated $925K.
Atalanta Sosnoff Capital first reported a position in Teva Pharmaceutical Industries Limited in Q4 2014 and held it in 5 quarters.
Atalanta Sosnoff Capital's Teva Pharmaceutical Industries Limited position peaked at $44.8M in Q3 2015.
444 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q3 2020.

Based on Atalanta Sosnoff Capital's 13F filing for Q3 2020, filed 14 Oct 2020.